Econazole Nitrate Cream, 1%

Manufacturer
Aurobindo Pharma Limited | APL HEALTHCARE LIMITED
Effective date
2026-05-12
Label type
Human Prescription Drug Label
Version
2
Source
full-release
Hydrated at
2026-05-31 22:19:01

Label at a glance#

ProductECONAZOLE NITRATE
Active ingredientECONAZOLE NITRATE
Label structure12 sections

Indications and uses

Econazole nitrate cream is indicated for topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor. 

Dosage and administration

Sufficient econazole nitrate cream should be applied to cover affected areas once daily in patients with tinea pedis, tinea cruris, tinea corporis, and tinea versicolor, and twice daily (morning and evening) in patients with cutaneous candidiasis. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, candidal infectio...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Econazole nitrate cream contains the antifungal agent, econazole nitrate USP 1%, in a water-miscible base consisting of benzoic acid, butylated hydroxyanisole, mineral oil, oleoyl polyoxylglycerides, pegoxol-7 stearate, and purified water. The white to off-white homogenous cream is for topical use only.


Chemically, econazole nitrate is (±)-1-[2,4-Dichloro-β-[(p-chlorobenzyl)oxy]phenethyl]-imidazole mononitrate. Its structure is as follows:


  Chemical StructureChemical Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

After topical application to the skin of normal subjects, systemic absorption of econazole nitrate is extremely low. Although most of the applied drug remains on the skin surface, drug concentrations were found in the stratum corneum, which, by far, exceeded the minimum inhibitory concentration for dermatophytes. Inhibitory concentrations were achieved in the epidermis and as deep as the middle region of the dermis. Less than 1% of the applied dose was recovered in the urine and feces.


Microbiology: Econazole nitrate has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section.

————————————————————————————————————

Dermatophytes                                                                                                       Yeasts

Epidermophyton floccosum       Trichophyton mentagrophytes                  Candida albicans

Microsporum audouini              Trichophyton rubrum                               Malassezia furfur

Microsporum canis                    Trichophyton tonsurans

Microsporum gypseum

—————————————————————————————————————

Econazole nitrate exhibits broad-spectrum antifungal activity against the following organisms in vitro, but the clinical significance of these data is unknown.

————————————————————————————————————

Dermatophytes                                                                                        Yeasts

Trichophyton verrucosum                                                              Candida guillermondii

                                                                                                       Candida parapsilosis

                                                                                                        Candida tropicalis

————————————————————————————————————


INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Econazole nitrate cream is indicated for topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor. 

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Econazole nitrate cream is contraindicated in individuals who have shown hypersensitivity to any of its ingredients. 

WARNINGS

WARNINGS SECTION

Econazole nitrate cream is not for ophthalmic use. 

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

If a reaction suggesting sensitivity or chemical irritation should occur, use of the medication should be discontinued.


For external use only. Avoid introduction of econazole nitrate cream into the eyes. 

Drug Interactions

DRUG INTERACTIONS SECTION

Warfarin

 

Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulation effect. Most cases reported product application with use under occlusion, genital application, or application to large body surface area which may increase the systemic absorption of econazole nitrate. Monitoring of International Normalized Ratio (INR) and/or prothrombin time may be indicated especially for patients who apply econazole to large body surface areas, in the genital area, or under occlusion.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term animal studies to determine carcinogenic potential have not been performed.


Oral administration of econazole nitrate in rats has been reported to produce prolonged gestation. Intravaginal administration in humans has not shown prolonged gestation or other adverse reproductive effects attributable to econazole nitrate therapy. 

Pregnancy

PREGNANCY SECTION

Econazole nitrate has not been shown to be teratogenic when administered orally to mice, rabbits or rats. Fetotoxic or embryotoxic effects were observed in Segment I oral studies with rats receiving 10 to 40 times the human dermal dose. Similar effects were observed in Segment II or Segment III studies with mice, rabbits and/or rats receiving oral doses 80 or 40 times the human dermal dose.


Econazole nitrate should be used in the first trimester of pregnancy only when the physician considers it essential to the welfare of the patient. The drug should be used during the second and third trimesters of pregnancy only if clearly needed. 

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether econazole nitrate is excreted in human milk. Following oral administration of econazole nitrate to lactating rats, econazole and/or metabolites were excreted in milk and were found in nursing pups. Also, in lactating rats receiving large oral doses (40 or 80 times the human dermal dose), there was a reduction in post partum viability of pups and survival to weaning; however, at these high doses, maternal toxicity was present and may have been a contributing factor. Caution should be exercised when econazole nitrate is administered to a nursing woman.

Geriatric Use

GERIATRIC USE SECTION

Clinical studies of econazole nitrate cream did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

During clinical trials, approximately 3% of patients treated with econazole nitrate cream, 1% reported side effects thought possibly to be due to the drug, consisting mainly of burning, itching, stinging, and erythema. One case of pruritic rash has also been reported. 

OVERDOSE

OVERDOSAGE SECTION

Overdosage of econazole nitrate in humans has not been reported to date. In mice, rats, guinea pigs and dogs, the oral LD 50 values were found to be 462, 668, 272, and > 160 mg/kg, respectively. 

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Sufficient econazole nitrate cream should be applied to cover affected areas once daily in patients with tinea pedis, tinea cruris, tinea corporis, and tinea versicolor, and twice daily (morning and evening) in patients with cutaneous candidiasis.


Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, candidal infections and tinea cruris and corporis should be treated for two weeks and tinea pedis for one month in order to reduce the possibility of recurrence. If a patient shows no clinical improvement after the treatment period, the diagnosis should be redetermined. Patients with tinea versicolor usually exhibit clinical and mycological clearing after two weeks of treatment. 

HOW SUPPLIED

HOW SUPPLIED SECTION

Econazole Nitrate Cream, 1% contains econazole nitrate USP. The white to off-white homogenous cream is available as follows:


15 g aluminum tube            NDC 59651-945-14


30 g aluminum tube            NDC 59651-945-30


85 g aluminum tube            NDC 59651-945-85


Store econazole nitrate cream below 30°C (86°F).


To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch for voluntary reporting of adverse reactions.


Distributed by:
Aurobindo Pharma USA, Inc.
279 Princeton-Hightstown Road
East Windsor, NJ 08520

Manufactured by:
Aurobindo Pharma Limited
Hyderabad-500 032, India


Revised: 04/2026

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-15 g (Tube Label)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 59651-945-14

Rx only

Econazole Nitrate Cream
1%

For Topical Use Only. Not for Ophthalmic Use.

AUROBINDO                                   Net Wt. 15 g

 

 PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-15 g (Tube Label)PACKAGE LABEL.PRINCIPAL DISPLAY PANEL-15 g (Tube Label)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 g (Tube Carton)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 59651-945-14

Rx only

Econazole Nitrate Cream
1%

For Topical Use Only. Not for Ophthalmic Use.

AUROBINDO                                   Net Wt. 15 g

 

   PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 g (Tube Carton)PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 g (Tube Carton)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
857366econazole nitrate 1 % Topical CreamPSN2
857366econazole nitrate 10 MG/ML Topical CreamSCD2
857366econazole nitrate 1 % Topical CreamSY2
857366econazole nitrate 10 MG per 1 GM Topical CreamSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ECONAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130359651945148GTIN-13: 0359651945148
EAN-13: 0359651945148
GTIN-12: 359651945148
UPC-A: 359651945148
GTIN storage (14 digits): 00359651945148
econazole-fig1.jpg
Data codeData MatrixP145022econazole-fig2.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
e3a04dc3-1a9e-4fba-b2b4-a18279351082Product name220180620
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
aa7deb41-117b-479c-8362-130fd1c222deProduct name120160112

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59651-945-14ECONAZOLE NITRATE1 in 1 CARTONCREAM12
59651-945-14ECONAZOLE NITRATE15 g in 1 TUBECREAM152
59651-945-30ECONAZOLE NITRATE30 g in 1 TUBECREAM302
59651-945-30ECONAZOLE NITRATE1 in 1 CARTONCREAM12
59651-945-85ECONAZOLE NITRATE85 g in 1 TUBECREAM852
59651-945-85ECONAZOLE NITRATE1 in 1 CARTONCREAM12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59651-94559651-945-14, 59651-945-30, 59651-945-85

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-03-16monthly-update2026-06-03 18:00:09

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210364-001ECONAZOLE NITRATEECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A210364-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-1884e616aacf4f…
2026-08-18 06:07:402026-07A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-188072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-185c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-185d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-184b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-1874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-1887673890dc5c…
2021-03-12 10:30 UTC2021-03A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-185aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-188869cabd3fbd…
2020-11-12 02:37 UTC2020-11A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-18c0c555d07b60…
2019-12-14 00:12 UTC2019-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-183f01610625f2…
2019-09-15 20:21 UTC2019-09A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-18b00525d2431f…
2019-07-19 19:46 UTC2019-07A210364-001ECONAZOLE NITRATE1%CREAM / TOPICALAB2018-04-18ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-186a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-181c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-189b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-183f0d92c62455…
2023-05-13 08:27 UTC2023-05A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18053a50430f4f…
2023-01-26 05:58 UTC2023-01A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-183bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-183a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210364-001ECONAZOLE NITRATE1%CREAM / TOPICAL2018-04-18f41ea6bd6efb…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A210364-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A210364-001AB1caaa826d4ba7…
2019-12-13 00:20 UTC2019-12A210364-001AB174a2ff9319b5…
2020-12-22 03:56 UTC2020-12A210364-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A210364-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A210364-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A210364-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A210364-001AB1ea99ee380514…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210364-001AB1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ECONAZOLE NITRATEECONAZOLE NITRATEAurobindo Pharma Limited74e5bbc9-eaea-405e-b64b-b3527c5ea0842026-05-12Warnings, Adverse reactionsExact identifier
ndc (package): 59651-945-14
ndc (package): 59651-945-85
ndc (package): 59651-945-30
ndc (product): 59651-945
ndc11 (package): 59651094585
ndc11 (package): 59651094530
ndc11 (package): 59651094514
spl id: 5773bc55-511b-4168-a917-7c1f69e0853e
spl set id: 74e5bbc9-eaea-405e-b64b-b3527c5ea084

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.